KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Return on Assets (2021 - 2025)

Recursion Pharmaceuticals' Return on Assets history spans 5 years, with the latest figure at 0.45% for Q4 2025.

  • For Q4 2025, Return on Assets fell 2.0% year-over-year to 0.45%; the TTM value through Dec 2025 reached 0.45%, down 2.0%, while the annual FY2025 figure was 0.44%, 0.0% changed from the prior year.
  • Return on Assets reached 0.45% in Q4 2025 per RXRX's latest filing, up from 0.53% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.21% in Q3 2021 to a low of 0.58% in Q1 2024.
  • Average Return on Assets over 5 years is 0.41%, with a median of 0.41% recorded in 2023.
  • Peak YoY movement for Return on Assets: dropped -20bps in 2024, then rose 17bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.29% in 2021, then dropped by -30bps to 0.37% in 2022, then tumbled by -36bps to 0.51% in 2023, then grew by 17bps to 0.43% in 2024, then fell by -5bps to 0.45% in 2025.
  • Per Business Quant, the three most recent readings for RXRX's Return on Assets are 0.45% (Q4 2025), 0.53% (Q3 2025), and 0.5% (Q2 2025).